Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

被引：0
|
作者：
Kim, Yi Rang [1 ]
Yoon, Dok Hyun [1 ]
Kim, Shin [1 ]
Lee, Kyoungmin [1 ]
Kang, Eun Hee [1 ]
Park, Jung Sun [1 ]
Yoo, Changhoon [1 ]
Kim, Jeong-eun [1 ]
Jo, Jae-Cheol [2 ]
Huh, Jooryung [3 ]
Kim, Jeong Hoon [4 ]
Lee, Sang-wook [5 ]
Suh, Cheolwon [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan 680749, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurosurg, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [2] Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Kim, Shin
    Park, Jung Sun
    Park, Chan-sik
    Lee, Sang-wook
    Kim, Jeong Hoon
    Ryu, Jin Sook
    Huh, Jooryung
    Suh, Cheolwon
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1657 - 1664
  • [3] Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma
    Jaewon Hyung
    Jung Yong Hong
    Dok Hyun Yoon
    Shin Kim
    Jung Sun Park
    Chan-sik Park
    Sang-wook Lee
    Jeong Hoon Kim
    Jin Sook Ryu
    Jooryung Huh
    Cheolwon Suh
    Annals of Hematology, 2019, 98 : 1657 - 1664
  • [4] Consolidative high dose chemotherapy and autologous stem cell transplant for patients with primary central nervous system lymphoma using thiotepa, busulfan, and cyclophosphamide conditioning regimen
    Young, Patricia Ann
    Kimaiyo, Davis Kipkemboi
    Chute, John P.
    Schiller, Gary J.
    Timmerman, John
    De Vos, Sven
    Eradat, Herbert Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma
    Delphine, Lebon
    Pierre-Edouard, Debureaux
    Bruno, Royer
    Berengere, Gruson
    Magalie, Joris
    Patrick, Votte
    Jean-Pierre, Marolleau
    Pierre, Morel
    MEDICAL SCIENCES, 2023, 11 (01)
  • [6] THIOTEPA BUSULFAN CYCLOPHOSPHAMIDE, A TOXIC CONDITIONING FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CENTRAL NERVOUS SYSTEM LYMPHOMA: REMISSION OR INFECTION?
    Debureaux, P-E
    Royer, B.
    Gruson, B.
    Votte, P.
    Joris, M.
    Damaj, G. L.
    Marolleau, J-P
    Delphine, L.
    HAEMATOLOGICA, 2017, 102 : 689 - 690
  • [7] Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen
    Young, Patricia A.
    Gaut, Daria
    Kimaiyo, Davis K.
    Grotts, Jonathan
    Romero, Tahmineh
    Chute, John
    Schiller, Gary
    de Vos, Sven
    Eradat, Herbert A.
    Timmerman, John
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07): : 468 - 479
  • [8] Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma
    Pasquini, Marcelo C.
    Le Rademacher, Jennifer
    Flowers, Christopher
    Lill, Michael
    Costa, Luciano J.
    Shore, Tsiporah B.
    Vaughan, William
    Craig, Michael
    Freytes, Cesar O.
    Shea, Thomas C.
    Horwitz, Mitchell E.
    Fay, Joseph W.
    Mineishi, Shin
    Rondelli, Damiano
    Mason, James
    Reddy, Vijay
    Braunschweig, Ira
    Ai, Weiyun
    Armstrong, Elizabeth
    Smith, Angela
    Zhao, Cathy
    Elekes, Agnes
    Carreras, Jeanette
    Kato, Kazunobu
    Waller, Edmund K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S162 - S162
  • [9] Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma
    Hänel, M
    Kröger, N
    Sonnenberg, S
    Bornhäuser, M
    Krüger, W
    Kroschinsky, F
    Hänel, A
    Metzner, B
    Birkmann, J
    Schmid, B
    Hoffknecht, MM
    Fiedler, F
    Ehninger, G
    Zander, AR
    ANNALS OF HEMATOLOGY, 2002, 81 (02) : 96 - 102
  • [10] Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma
    M. Hänel
    N. Kröger
    S. Sonnenberg
    M. Bornhäuser
    W. Krüger
    F. Kroschinsky
    A. Hänel
    B. Metzner
    J. Birkmann
    B. Schmid
    M. Hoffknecht
    F. Fiedler
    G. Ehninger
    A. Zander
    Annals of Hematology, 2002, 81 : 96 - 102
12345